MentionFox
Home › Executive changes › Ardent Health, Inc.
Leadership changes · ARDT · SEC Form 8-K, Item 5.02

Leadership changes at Ardent Health, Inc. (2026)

Before you join, sell to or invest in Ardent Health, Inc.

MentionFox check on Ardent Health, Inc.: no red flags found in 3 sources (checked 14 November 2026). mentionfox.com/c/executive-changes/ardent-health

Check Ardent Health, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Ardent Health, Inc.?

Who joined and who left Ardent Health, Inc. (ARDT)? 3 filings reported from 2026-03-27 to 2026-10-23, each cited to the company's own filing.

As of November 14, 2026, Ardent Health, Inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 27, 2026 to October 23, 2026 (Form 8-K, October 23, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Sell to companies like Ardent Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-10-23
  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-06-02
  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-03-27
Changes3
Latest filing2026-10-23

Ardent Health, Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-27 to 2026-10-23. Every row below is cited to the filing it comes from, and this page adds each new change as Ardent Health, Inc. files it.

Also on the record for Ardent Health, Inc.

DateRecordFigureOur pageSource
July 18, 2024IPO filing, Form 424B4$16 a shareIPO filingsSource
July 15, 2024IPO filing, Form S-1/A$20 to $22 a shareIPO filingsSource
July 10, 2024IPO filing, Form S-1/A—IPO filingsSource
July 8, 2024IPO filing, Form S-1/A$20 to $22 a shareIPO filingsSource

Selling to them or working with them? See who runs Ardent Health, Inc. now and the warning signs.

Free to see. No signup.

Want the whole picture on Ardent Health, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Ardent Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Ardent Health, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    7 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-10-23Reportednot named in the filing8-K, 2026-10-23
2026-06-02Reportednot named in the filing8-K, 2026-06-02
2026-03-27Reportednot named in the filing8-K, 2026-03-27
Selling to Ardent Health, Inc.?

New leaders reset buying decisions — get the Full Report on Ardent Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Ardent Health, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Ardent Health, Inc., with the record behind each one.

Find candidates like senior executive at Ardent Health, Inc.

Every change, in the filing's words

Filed 2026-10-23 · 8-K

Reported

On October 19, 2026, following notice to Mr. Bonick and a hearing at which he was afforded an opportunity to be heard, the Board determined that facts and circumstances discovered after the Separation Date would have given the Company grounds to terminate Mr. Bonick's employment for "Cause" as of the Separation Date.

Also stated in this filing

  • As previously disclosed, Martin J. Bonick's employment as President and Chief Executive Officer of Ardent Health, Inc. (the "Company") and his service as a member of the Company's Board of Directors (the "Board") ended effective June 2, 2026 (the "Separation Date").
  • In connection with his departure, Mr. Bonick and AHS Management Company, Inc. ("AHS"), a subsidiary of the Company, entered into a Separation Agreement and General Release, dated as of June 26, 2026 (the "Separation Agreement"), providing for severance benefits consistent with a termination of employment without "Cause" (as defined in Mr. Bonick's Amended and Restated Employment Agreement with AHS, effective as of January 10, 2025 (the "Employment Agreement")).
  • Accordingly, pursuant to the terms of the Employment Agreement, as preserved by the Separation Agreement, the Company has recharacterized Mr. Bonick's separation as of the Separation Date as a termination for "Cause." The Board's final determination followed a review by the Board where it determined that Mr. Bonick failed to disclose fully to the Board and the Company compensation received from third parties otherwise required to be reported by Company policies.
  • The Company has determined that none of the Company's financial statements or previously disclosed financial results are required to be revised or corrected as a result of the foregoing.
Filed 2026-06-02 · 8-K

Reported

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Also stated in this filing

  • On June 2, 2026 (the "Effective Date"), the Board of Directors (the "Board") of Ardent Health, Inc. (the "Company") appointed Dave Caspers, who previously served as the Company's Chief Operating Officer, as the Company's President and Chief Executive Officer and as a member of the Board.
  • Mr. Caspers, age 55, has served as the Company's Chief Operating Officer since March 31, 2025.
  • Prior to joining the Company, Mr. Caspers served as chief stores officer at Leslie's, Inc. ("Leslie's"), a leading direct-to-consumer pool and spa care brand, from October 2023 to March 2025.
  • Prior to that, Mr. Caspers served as the senior vice president of retail operations at Leslie's from May 2023 to October 2023.
  • Prior to joining Leslie's, Mr. Caspers served as the vice president, omni channel retail healthcare operations for Walmart Inc., a multinational retailer, from August 2022 to May 2023, where he was responsible for the execution and results for Walmart Health, including overseeing large-scale healthcare systems and omnichannel care delivery, including responsibility for in-store clinics and virtual health services.
  • From August 2015 through August 2022, Mr. Caspers held various roles for Banner Health, a large non-profit health system, including vice president healthcare operations, vice president special project BUMD, and vice president patient experience.
Filed 2026-03-27 · 8-K

Reported

On March 24, 2026, Ardent Health, Inc. (the "Company") and Ethan Chernin determined that Mr. Chernin would no longer serve as President, Hospital Services and would depart the Company effective that day.

Also stated in this filing

  • The Company treated Mr. Chernin's departure from the Company as a "Qualifying Termination" pursuant to the Company's Executive Severance Plan (the "Severance Plan").
  • Mr. Chernin will be entitled to receive severance and related benefits for such a separation, subject to compliance with the terms and conditions of the Severance Plan.

Tools for this story

Each opens in a new tab, filled in for Ardent Health, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/ardent-health
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
What changed at the top of Ardent Health, Inc.? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/ardent-health